| 1. Kansy M, Senner F, Gubernator K.. (1998) Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes., 41 (7): [PMID:9544199] [10.1021/jm970530e] |
| 2. Jorgensen WL, Duffy EM.. (2000) Prediction of drug solubility from Monte Carlo simulations., 10 (11): [PMID:10866370] [10.1016/s0960-894x(00)00172-4] |
| 3. Andrews PR, Craik DJ, Martin JL.. (1984) Functional group contributions to drug-receptor interactions., 27 (12): [PMID:6094812] [10.1021/jm00378a021] |
| 4. Frostell-Karlsson A, Remaeus A, Roos H, Andersson K, Borg P, Hämäläinen M, Karlsson R.. (2000) Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels., 43 (10): [PMID:10821711] [10.1021/jm991174y] |
| 5. Yoshida F, Topliss JG.. (2000) QSAR model for drug human oral bioavailability., 43 (13): [PMID:10891117] [10.1021/jm0000564] |
| 6. Mandagere AK, Thompson TN, Hwang KK.. (2002) Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates., 45 (2): [PMID:11784135] [10.1021/jm010152k] |
| 7. Thaisrivongs S, Tomich PK, Watenpaugh KD, Chong KT, Howe WJ, Yang CP, Strohbach JW, Turner SR, McGrath JP, Bohanon MJ.. (1994) Structure-based design of HIV protease inhibitors: 4-hydroxycoumarins and 4-hydroxy-2-pyrones as non-peptidic inhibitors., 37 (20): [PMID:7932546] [10.1021/jm00046a002] |
| 8. Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL.. (2001) Cheminformatic models to predict binding affinities to human serum albumin., 44 (25): [PMID:11728183] [10.1021/jm010960b] |
| 9. Kontogiorgis CA, Hadjipavlou-Litina DJ.. (2004) Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage., 14 (3): [PMID:14741253] [10.1016/j.bmcl.2003.11.060] |
| 10. Afzelius L, Zamora I, Masimirembwa CM, Karlén A, Andersson TB, Mecucci S, Baroni M, Cruciani G.. (2004) Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors., 47 (4): [PMID:14761192] [10.1021/jm030972s] |
| 11. Wohnsland F, Faller B.. (2001) High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes., 44 (6): [PMID:11300874] [10.1021/jm001020e] |
| 12. Caron G, Ermondi G.. (2005) Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk)., 48 (9): [PMID:15857133] [10.1021/jm048980b] |
| 13. Kontogiorgis CA, Hadjipavlou-Litina DJ.. (2005) Synthesis and antiinflammatory activity of coumarin derivatives., 48 (20): [PMID:16190766] [10.1021/jm0580149] |
| 14. Cui P, Macdonald TL, Chen M, Nadler JL.. (2006) Synthesis and biological evaluation of lisofylline (LSF) analogs as a potential treatment for Type 1 diabetes., 16 (13): [PMID:16650991] [10.1016/j.bmcl.2006.04.036] |
| 15. Gebauer M.. (2007) Synthesis and structure-activity relationships of novel warfarin derivatives., 15 (6): [PMID:17275317] [10.1016/j.bmc.2007.01.014] |
| 16. Thorarensen A, Sarver RW, Tian F, Ho A, Romero DL, Marotti KR.. (2007) Human serum albumin binding assay based on displacement of a non selective fluorescent inhibitor., 17 (16): [PMID:17560104] [10.1016/j.bmcl.2007.05.077] |
| 17. Ottaviani G, Martel S, Carrupt PA.. (2007) In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities., 50 (4): [PMID:17300161] [10.1021/jm0611105] |
| 18. Lázaro E, Lowe PJ, Briand X, Faller B.. (2008) New approach to measure protein binding based on a parallel artificial membrane assay and human serum albumin., 51 (7): [PMID:18348514] [10.1021/jm7012826] |
| 19. Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergström CA, Artursson P.. (2008) Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1., 51 (19): [PMID:18788725] [10.1021/jm8003152] |
| 20. Pedersen JM, Matsson P, Bergström CA, Norinder U, Hoogstraate J, Artursson P.. (2008) Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)., 51 (11): [PMID:18457386] [10.1021/jm7015683] |
| 21. Li H, Sun J, Sui X, Liu J, Yan Z, Liu X, Sun Y, He Z.. (2009) First-principle, structure-based prediction of hepatic metabolic clearance values in human., 44 (4): [PMID:18768239] [10.1016/j.ejmech.2008.07.027] |
| 22. Imaeda Y, Kuroita T, Sakamoto H, Kawamoto T, Tobisu M, Konishi N, Hiroe K, Kawamura M, Tanaka T, Kubo K.. (2008) Discovery of imidazo[1,5-c]imidazol-3-ones: weakly basic, orally active factor Xa inhibitors., 51 (12): [PMID:18507371] [10.1021/jm701548u] |
| 23. Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, Miller HR, El-Kattan A.. (2009) Physicochemical determinants of human renal clearance., 52 (15): [PMID:19445515] [10.1021/jm900403j] |
| 24. Dreassi E, Zizzari AT, Falchi F, Schenone S, Santucci A, Maga G, Botta M.. (2009) Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data., 44 (9): [PMID:19410338] [10.1016/j.ejmech.2009.03.039] |
| 25. Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD.. (2010) Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination., 53 (3): [PMID:20070106] [10.1021/jm901371v] |
| 26. Lee PH, Conradi R, Shanmugasundaram V.. (2010) Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay., 20 (1): [PMID:19963379] [10.1016/j.bmcl.2009.11.039] |
| 27. Du-Cuny L, Song Z, Moses S, Powis G, Mash EA, Meuillet EJ, Zhang S.. (2009) Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain., 17 (19): [PMID:19734051] [10.1016/j.bmc.2009.08.022] |
| 28. Jeong HC, Park NJ, Chae CH, Musilek K, Kassa J, Kuca K, Jung YS.. (2009) Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent., 17 (17): [PMID:19665386] [10.1016/j.bmc.2009.07.043] |
| 29. Miyazaki H, Sai H, Ohmizu H, Murakami J, Ohtani A, Ogiku T.. (2010) Synthesis and evaluation of 1,4-diphenylbutadiene derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) production., 18 (5): [PMID:20138768] [10.1016/j.bmc.2010.01.032] |
| 30. Stromich JJ, Weber AK, Mirzaei YR, Caldwell MD, Lewis DE.. (2010) New adjuvants to enhance anticoagulant activity of warfarin., 20 (6): [PMID:20167480] [10.1016/j.bmcl.2010.01.123] |
| 31. Sui X, Sun J, Li H, Wang Y, Liu J, Liu X, Zhang W, Chen L, He Z.. (2009) Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data., 44 (11): [PMID:19586686] [10.1016/j.ejmech.2009.06.004] |
| 32. Avdeef A, Tam KY.. (2010) How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?, 53 (9): [PMID:20373811] [10.1021/jm901846t] |
| 33. Abdelhafez OM, Amin KM, Batran RZ, Maher TJ, Nada SA, Sethumadhavan S.. (2010) Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives., 18 (10): [PMID:20435480] [10.1016/j.bmc.2010.04.009] |
| 34. Kokel D, Bryan J, Laggner C, White R, Cheung CY, Mateus R, Healey D, Kim S, Werdich AA, Haggarty SJ, Macrae CA, Shoichet B, Peterson RT.. (2010) Rapid behavior-based identification of neuroactive small molecules in the zebrafish., 6 (3): [PMID:20081854] [10.1038/nchembio.307] |
| 35. Hopkins S, Scorneaux B, Huang Z, Murray MG, Wring S, Smitley C, Harris R, Erdmann F, Fischer G, Ribeill Y.. (2010) SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro., 54 (2): [PMID:19933795] [10.1128/aac.00660-09] |
| 36. Gozalbes R, Pineda-Lucena A.. (2010) QSAR-based solubility model for drug-like compounds., 18 (19): [PMID:20810286] [10.1016/j.bmc.2010.08.003] |
| 37. Karlsson BC, Rosengren AM, Näslund I, Andersson PO, Nicholls IA.. (2010) Synthetic human serum albumin Sudlow I binding site mimics., 53 (22): [PMID:20973485] [10.1021/jm100491v] |
| 38. PubChem BioAssay data set, |
| 39. PubChem BioAssay data set, |
| 40. Obach RS, Lombardo F, Waters NJ.. (2008) Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds., 36 (7): [PMID:18426954] [10.1124/dmd.108.020479] |
| 41. Jolivette LJ, Ward KW.. (2005) Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure., 94 (7): [PMID:15920768] [10.1002/jps.20373] |
| 42. Chen T, Benmohamed R, Arvanites AC, Ralay Ranaivo H, Morimoto RI, Ferrante RJ, Watterson DM, Kirsch DR, Silverman RB.. (2011) Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis., 19 (1): [PMID:21095130] [10.1016/j.bmc.2010.10.052] |
| 43. Talevi A, Goodarzi M, Ortiz EV, Duchowicz PR, Bellera CL, Pesce G, Castro EA, Bruno-Blanch LE.. (2011) Prediction of drug intestinal absorption by new linear and non-linear QSPR., 46 (1): [PMID:21112128] [10.1016/j.ejmech.2010.11.005] |
| 44. Greene N, Fisk L, Naven RT, Note RR, Patel ML, Pelletier DJ.. (2010) Developing structure-activity relationships for the prediction of hepatotoxicity., 23 (7): [PMID:20553011] [10.1021/tx1000865] |
| 45. Ekins S, Williams AJ, Xu JJ.. (2010) A predictive ligand-based Bayesian model for human drug-induced liver injury., 38 (12): [PMID:20843939] [10.1124/dmd.110.035113] |
| 46. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 47. Matthews EJ, Kruhlak NL, Weaver JL, Benz RD, Contrera JF.. (2004) Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling., 1 (4): [PMID:16472241] [10.2174/1570163043334794] |
| 48. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF.. (2008) Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models., 18 (2): [PMID:20020916] [10.1080/15376510701857262] |
| 49. Gozalbes R, Jacewicz M, Annand R, Tsaioun K, Pineda-Lucena A.. (2011) QSAR-based permeability model for drug-like compounds., 19 (8): [PMID:21458999] [10.1016/j.bmc.2011.03.011] |
| 50. Giannetti AM, Wong H, Dijkgraaf GJ, Dueber EC, Ortwine DF, Bravo BJ, Gould SE, Plise EG, Lum BL, Malhi V, Graham RA.. (2011) Identification, characterization, and implications of species-dependent plasma protein binding for the oral Hedgehog pathway inhibitor vismodegib (GDC-0449)., 54 (8): [PMID:21438527] [10.1021/jm1008924] |
| 51. Buttar D, Colclough N, Gerhardt S, MacFaul PA, Phillips SD, Plowright A, Whittamore P, Tam K, Maskos K, Steinbacher S, Steuber H.. (2010) A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions., 18 (21): [PMID:20869876] [10.1016/j.bmc.2010.08.052] |
| 52. de Oliveira CM, Silva GH, Regasini LO, Flausino O, López SN, Abissi BM, Berlinck RG, Sette LD, Bonugli-Santos RC, Rodrigues A, Bolzani Vda S, Araujo AR.. (2011) Xylarenones C-E from an endophytic fungus isolated from Alibertia macrophylla., 74 (6): [PMID:21510613] [10.1021/np1005983] |
| 53. Kamisuki S, Shirakawa T, Kugimiya A, Abu-Elheiga L, Choo HY, Yamada K, Shimogawa H, Wakil SJ, Uesugi M.. (2011) Synthesis and evaluation of diarylthiazole derivatives that inhibit activation of sterol regulatory element-binding proteins., 54 (13): [PMID:21561152] [10.1021/jm200304y] |
| 54. PubChem BioAssay data set, |
| 55. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
| 56. Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W.. (2011) FDA-approved drug labeling for the study of drug-induced liver injury., 16 (15-16): [PMID:21624500] [10.1016/j.drudis.2011.05.007] |
| 57. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 58. Sashidhara KV, Kumar A, Kumar M, Singh S, Jain M, Dikshit M.. (2011) Synthesis of novel 3-carboxamide-benzocoumarin derivatives as orally active antithrombotic agents., 21 (23): [PMID:22004722] [10.1016/j.bmcl.2011.09.100] |
| 59. Mladenović M, Mihailović M, Bogojević D, Vuković N, Sukdolak S, Matić S, Nićiforović N, Mihailović V, Mašković P, Vrvić MM, Solujić S.. (2012) Biochemical and pharmacological evaluation of 4-hydroxychromen-2-ones bearing polar C-3 substituents as anticoagulants., 54 [PMID:22633008] [10.1016/j.ejmech.2012.04.036] |
| 60. Pothier J, Riederer MA, Peter O, Leroy X, Valdenaire A, Gnerre C, Fretz H.. (2012) Novel 2-(2-(benzylthio)-1H-benzo[d]imidazol-1-yl)acetic acids: discovery and hit-to-lead evolution of a selective CRTh2 receptor antagonist chemotype., 22 (14): [PMID:22726929] [10.1016/j.bmcl.2012.05.087] |
| 61. Sakatis MZ, Reese MJ, Harrell AW, Taylor MA, Baines IA, Chen L, Bloomer JC, Yang EY, Ellens HM, Ambroso JL, Lovatt CA, Ayrton AD, Clarke SE.. (2012) Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., 25 (10): [PMID:22931300] [10.1021/tx300075j] |
| 62. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P.. (2012) Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions., 55 (10): [PMID:22541068] [10.1021/jm300212s] |
| 63. azarenkow A, Nawrot-Modranka J, Brzezinska E, Krajewska U, Rozalski M. (2012) Synthesis, preliminary cytotoxicity evaluation of new 3-formylchromone hydrazones and phosphorohydrazone derivatives of coumarin and chromone, 21 (8): [10.1007/s00044-011-9703-4] |
| 64. Verma A, Giridhar R, Kanhed A, Sinha A, Modh P, Yadav MR.. (2013) Novel 2-aminobenzamides as potential orally active antithrombotic agents., 4 (1): [PMID:24900559] [10.1021/ml300217f] |
| 65. Fretz H, Valdenaire A, Pothier J, Hilpert K, Gnerre C, Peter O, Leroy X, Riederer MA.. (2013) Identification of 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid (setipiprant/ACT-129968), a potent, selective, and orally bioavailable chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonist., 56 (12): [PMID:23721423] [10.1021/jm400122f] |
| 66. Draoui N, Schicke O, Fernandes A, Drozak X, Nahra F, Dumont A, Douxfils J, Hermans E, Dogné JM, Corbau R, Marchand A, Chaltin P, Sonveaux P, Feron O, Riant O.. (2013) Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells., 21 (22): [PMID:24095010] [10.1016/j.bmc.2013.09.010] |
| 67. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP.. (2013) Structure-based identification of OATP1B1/3 inhibitors., 83 (6): [PMID:23571415] [10.1124/mol.112.084152] |
| 68. Cinelli MA, Li H, Chreifi G, Martásek P, Roman LJ, Poulos TL, Silverman RB.. (2014) Simplified 2-aminoquinoline-based scaffold for potent and selective neuronal nitric oxide synthase inhibition., 57 (4): [PMID:24472039] [10.1021/jm401838x] |
| 69. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
| 70. PubChem BioAssay data set, |
| 71. PubChem BioAssay data set, |
| 72. PubChem BioAssay data set, |
| 73. PubChem BioAssay data set, |
| 74. Muraglia M, De Bellis M, Catalano A, Carocci A, Franchini C, Carrieri A, Fortugno C, Bertucci C, Desaphy JF, De Luca A, Conte Camerino D, Corbo F.. (2014) N-aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels., 57 (6): [PMID:24568674] [10.1021/jm401864b] |
| 75. Khanfar MA, Quinti L, Wang H, Choi SH, Kazantsev AG, Silverman RB.. (2014) Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors., 76 [PMID:24602787] [10.1016/j.ejmech.2014.02.003] |
| 76. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds, [10.6019/CHEMBL3301361] |
| 77. Yang S, Shi W, Xing D, Zhao Z, Lv F, Yang L, Yang Y, Hu W.. (2014) Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria., 86 [PMID:25151577] [10.1016/j.ejmech.2014.07.106] |
| 78. Nomme J, Li Z, Gipson RM, Wang J, Armijo AL, Le T, Poddar S, Smith T, Santarsiero BD, Nguyen HA, Czernin J, Alexandrova AN, Jung ME, Radu CG, Lavie A.. (2014) Structure-guided development of deoxycytidine kinase inhibitors with nanomolar affinity and improved metabolic stability., 57 (22): [PMID:25341194] [10.1021/jm501124j] |
| 79. Shao YX, Huang M, Cui W, Feng LJ, Wu Y, Cai Y, Li Z, Zhu X, Liu P, Wan Y, Ke H, Luo HB.. (2014) Discovery of a phosphodiesterase 9A inhibitor as a potential hypoglycemic agent., 57 (24): [PMID:25432025] [10.1021/jm500836h] |
| 80. Mukherjee P, Li H, Sevrioukova I, Chreifi G, Martásek P, Roman LJ, Poulos TL, Silverman RB.. (2015) Novel 2,4-disubstituted pyrimidines as potent, selective, and cell-permeable inhibitors of neuronal nitric oxide synthase., 58 (3): [PMID:25489882] [10.1021/jm501719e] |
| 81. Papadopoulou MV, Bloomer WD, Lepesheva GI, Rosenzweig HS, Kaiser M, Aguilera-Venegas B, Wilkinson SR, Chatelain E, Ioset JR.. (2015) Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents., 58 (3): [PMID:25580906] [10.1021/jm5015742] |
| 82. Farrell TL, Poquet L, Dew TP, Barber S, Williamson G.. (2012) Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study., 40 (2): [PMID:22096083] [10.1124/dmd.111.041665] |
| 83. Nakayama S, Takakusa H, Watanabe A, Miyaji Y, Suzuki W, Sugiyama D, Shiosakai K, Honda K, Okudaira N, Izumi T, Okazaki O.. (2011) Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites., 39 (7): [PMID:21467212] [10.1124/dmd.111.039180] |
| 84. Longhi R, Corbioli S, Fontana S, Vinco F, Braggio S, Helmdach L, Schiller J, Boriss H.. (2011) Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method., 39 (2): [PMID:21071520] [10.1124/dmd.110.036095] |
| 85. Curran RE, Claxton CR, Hutchison L, Harradine PJ, Martin IJ, Littlewood P.. (2011) Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding., 39 (3): [PMID:21098647] [10.1124/dmd.110.036988] |
| 86. Di L, Umland JP, Chang G, Huang Y, Lin Z, Scott DO, Troutman MD, Liston TE.. (2011) Species independence in brain tissue binding using brain homogenates., 39 (7): [PMID:21474681] [10.1124/dmd.111.038778] |
| 87. Drug metabolism data, |
| 88. Davis DC, Mohammad H, Kyei-Baffour K, Younis W, Creemer CN, Seleem MN, Dai M.. (2015) Discovery and characterization of aryl isonitriles as a new class of compounds versus methicillin- and vancomycin-resistant Staphylococcus aureus., 101 [PMID:26164843] [10.1016/j.ejmech.2015.06.031] |
| 89. (2012) Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders, |
| 90. Cinelli MA, Li H, Pensa AV, Kang S, Roman LJ, Martásek P, Poulos TL, Silverman RB.. (2015) Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase., 58 (21): [PMID:26469213] [10.1021/acs.jmedchem.5b01330] |
| 91. Zmuda F, Malviya G, Blair A, Boyd M, Chalmers AJ, Sutherland A, Pimlott SL.. (2015) Synthesis and Evaluation of a Radioiodinated Tracer with Specificity for Poly(ADP-ribose) Polymerase-1 (PARP-1) in Vivo., 58 (21): [PMID:26469301] [10.1021/acs.jmedchem.5b01324] |
| 92. Kaplan A, Stockwell BR.. (2015) Structural Elucidation of a Small Molecule Inhibitor of Protein Disulfide Isomerase., 6 (9): [PMID:26500720] [10.1021/acsmedchemlett.5b00014] |
| 93. Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.. (2016) Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective α1A-Adrenoceptor Antagonists., 59 (8): [PMID:27031406] [10.1021/acs.jmedchem.5b02023] |
| 94. Fraser C, Dawson JC, Dowling R, Houston DR, Weiss JT, Munro AF, Muir M, Harrington L, Webster SP, Frame MC, Brunton VG, Patton EE, Carragher NO, Unciti-Broceta A.. (2016) Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase., 59 (10): [PMID:27115835] [10.1021/acs.jmedchem.6b00065] |
| 95. Seleem MA, Disouky AM, Mohammad H, Abdelghany TM, Mancy AS, Bayoumi SA, Elshafeey A, El-Morsy A, Seleem MN, Mayhoub AS.. (2016) Second-Generation Phenylthiazole Antibiotics with Enhanced Pharmacokinetic Properties., 59 (10): [PMID:27187739] [10.1021/acs.jmedchem.6b00233] |
| 96. WHO Anatomical Therapeutic Chemical Classification, |
| 97. DrugMatrix, [10.6019/CHEMBL3885881] |
| 98. Singh K, Okombo J, Brunschwig C, Ndubi F, Barnard L, Wilkinson C, Njogu PM, Njoroge M, Laing L, Machado M, Prudêncio M, Reader J, Botha M, Nondaba S, Birkholtz LM, Lauterbach S, Churchyard A, Coetzer TL, Burrows JN, Yeates C, Denti P, Wiesner L, Egan TJ, Wittlin S, Chibale K.. (2017) Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse Model., 60 (4): [PMID:28094524] [10.1021/acs.jmedchem.6b01641] |
| 99. Yahia E, Mohammad H, Abdelghany TM, Fayed E, Seleem MN, Mayhoub AS.. (2017) Phenylthiazole antibiotics: A metabolism-guided approach to overcome short duration of action., 126 [PMID:27918995] [10.1016/j.ejmech.2016.11.042] |
| 100. Galasiti Kankanamalage AC, Kim Y, Rathnayake AD, Alliston KR, Butler MM, Cardinale SC, Bowlin TL, Groutas WC, Chang KO.. (2017) Design, Synthesis, and Evaluation of Novel Prodrugs of Transition State Inhibitors of Norovirus 3CL Protease., 60 (14): [PMID:28671827] [10.1021/acs.jmedchem.7b00497] |
| 101. Eissa IH, Mohammad H, Qassem OA, Younis W, Abdelghany TM, Elshafeey A, Abd Rabo Moustafa MM, Seleem MN, Mayhoub AS.. (2017) Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus., 130 [PMID:28249208] [10.1016/j.ejmech.2017.02.044] |
| 102. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T.. (2012) Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification., 40 (12): [PMID:22961681] [10.1124/dmd.112.047068] |
| 103. Qi Q, Obianyo O, Du Y, Fu H, Li S, Ye K.. (2017) Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis., 60 (17): [PMID:28820254] [10.1021/acs.jmedchem.7b00228] |
| 104. Boubia B, Poupardin O, Barth M, Binet J, Peralba P, Mounier L, Jacquier E, Gauthier E, Lepais V, Chatar M, Ferry S, Thourigny A, Guillier F, Llacer J, Amaudrut J, Dodey P, Lacombe O, Masson P, Montalbetti C, Wettstein G, Luccarini JM, Legendre C, Junien JL, Broqua P.. (2018) Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate., 61 (6): [PMID:29446942] [10.1021/acs.jmedchem.7b01285] |
| 105. Joshi MC, Okombo J, Nsumiwa S, Ndove J, Taylor D, Wiesner L, Hunter R, Chibale K, Egan TJ.. (2017) 4-Aminoquinoline Antimalarials Containing a Benzylmethylpyridylmethylamine Group Are Active against Drug Resistant Plasmodium falciparum and Exhibit Oral Activity in Mice., 60 (24): [PMID:29185748] [10.1021/acs.jmedchem.7b01537] |
| 106. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 107. Do HT, Wang HY, Li H, Chreifi G, Poulos TL, Silverman RB.. (2017) Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker., 60 (22): [PMID:29091437] [10.1021/acs.jmedchem.7b01356] |
| 108. Pensa AV, Cinelli MA, Li H, Chreifi G, Mukherjee P, Roman LJ, Martásek P, Poulos TL, Silverman RB.. (2017) Hydrophilic, Potent, and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase Inhibitors., 60 (16): [PMID:28776992] [10.1021/acs.jmedchem.7b00835] |
| 109. Cinelli MA, Li H, Chreifi G, Poulos TL, Silverman RB.. (2017) Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors., 60 (9): [PMID:28422508] [10.1021/acs.jmedchem.7b00259] |
| 110. Risinger AL, Li J, Du L, Benavides R, Robles AJ, Cichewicz RH, Kuhn JG, Mooberry SL.. (2017) Pharmacokinetic Analysis and in Vivo Antitumor Efficacy of Taccalonolides AF and AJ., 80 (2): [PMID:28112516] [10.1021/acs.jnatprod.6b00944] |
| 111. Pedron J, Boudot C, Hutter S, Bourgeade-Delmas S, Stigliani JL, Sournia-Saquet A, Moreau A, Boutet-Robinet E, Paloque L, Mothes E, Laget M, Vendier L, Pratviel G, Wyllie S, Fairlamb A, Azas N, Courtioux B, Valentin A, Verhaeghe P.. (2018) Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study., 155 [PMID:29885575] [10.1016/j.ejmech.2018.06.001] |
| 112. Papadopoulou MV, Bloomer WD, Rosenzweig HS.. (2017) The antitubercular activity of various nitro(triazole/imidazole)-based compounds., 25 (21): [PMID:28993106] [10.1016/j.bmc.2017.09.037] |
| 113. Hagras M, Mohammad H, Mandour MS, Hegazy YA, Ghiaty A, Seleem MN, Mayhoub AS.. (2017) Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA and VRSA)., 60 (9): [PMID:28436655] [10.1021/acs.jmedchem.7b00392] |
| 114. Siddiqui-Jain A, Hoj JP, Cescon DW, Hansen MD.. (2018) Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization., 28 (5): [PMID:29433928] [10.1016/j.bmcl.2018.01.053] |
| 115. Lemieux MR, Siricilla S, Mitachi K, Eslamimehr S, Wang Y, Yang D, Pressly JD, Kong Y, Park F, Franzblau SG, Kurosu M.. (2018) An antimycobacterial pleuromutilin analogue effective against dormant bacilli., 26 (17): [PMID:30145051] [10.1016/j.bmc.2018.07.034] |
| 116. Unpublished dataset, |
| 117. Franck Touret, Magali Gilles, Karine Barral, Antoine Nougairède, Etienne Decroly, Xavier de Lamballerie, Bruno Coutard. (2020) In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication, [10.1101/2020.04.03.023846] |
| 118. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
| 119. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson. (2020) Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2, [10.1101/2020.04.21.054387] |
| 120. Aretz CD, Vadukoot AK, Hopkins CR.. (2019) Discovery of Small Molecule Renal Outer Medullary Potassium (ROMK) Channel Inhibitors: A Brief History of Medicinal Chemistry Approaches To Develop Novel Diuretic Therapeutics., 62 (19): [PMID:31034224] [10.1021/acs.jmedchem.8b01891] |
| 121. Dargó G, Bajusz D, Simon K, Müller J, Balogh GT.. (2020) Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design., 63 (4): [PMID:31995375] [10.1021/acs.jmedchem.0c00046] |
| 122. Hammad A, Abutaleb NS, Elsebaei MM, Norvil AB, Alswah M, Ali AO, Abdel-Aleem JA, Alattar A, Bayoumi SA, Gowher H, Seleem MN, Mayhoub AS.. (2019) From Phenylthiazoles to Phenylpyrazoles: Broadening the Antibacterial Spectrum toward Carbapenem-Resistant Bacteria., 62 (17): [PMID:31369262] [10.1021/acs.jmedchem.9b00720] |
| 123. Kang D, Zhang H, Wang Z, Zhao T, Ginex T, Luque FJ, Yang Y, Wu G, Feng D, Wei F, Zhang J, De Clercq E, Pannecouque C, Chen CH, Lee KH, Murugan NA, Steitz TA, Zhan P, Liu X.. (2019) Identification of Dihydrofuro[3,4- d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties., 62 (3): [PMID:30624934] [10.1021/acs.jmedchem.8b01656] |
| 124. Adebesin AM, Wesser T, Vijaykumar J, Konkel A, Paudyal MP, Lossie J, Zhu C, Westphal C, Puli N, Fischer R, Schunck WH, Falck JR.. (2019) Development of Robust 17(R),18(S)-Epoxyeicosatetraenoic Acid (17,18-EEQ) Analogues as Potential Clinical Antiarrhythmic Agents., 62 (22): [PMID:31693857] [10.1021/acs.jmedchem.9b00952] |
| 125. Xing H, Houston SD, Chen X, Jin DY, Savage GP, Tie JK, Williams CM.. (2019) Determining the necessity of phenyl ring π-character in warfarin., 29 (15): [PMID:31147103] [10.1016/j.bmcl.2019.05.039] |
| 126. Rana P, Will Y, Nadanaciva S, Jones LH.. (2016) Development of a cell viability assay to assess drug metabolite structure-toxicity relationships., 26 (16): [PMID:27397500] [10.1016/j.bmcl.2016.06.088] |
| 127. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 128. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 129. Ivashchenko AA, Mitkin OD, Jones JC, Nikitin AV, Koryakova AG, Ryakhovskiy A, Karapetian RN, Kravchenko DV, Aladinskiy V, Leneva IA, Falynskova IN, Glubokova EA, Govorkova EA, Ivachtchenko AV.. (2020) Non-rigid Diarylmethyl Analogs of Baloxavir as Cap-Dependent Endonuclease Inhibitors of Influenza Viruses., 63 (17): [PMID:32787099] [10.1021/acs.jmedchem.0c00565] |
| 130. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 131. Hou M,Lv M,Zhang X,Wang Y,Zhao S,Wu J,Peng S,Zhao M. (2020) Discovery of novel (6S/12aS)-heptachpyridone capable of inhibiting thrombosis in vivo., 30 (19): [PMID:32730945] [10.1016/j.bmcl.2020.127440] |
| 132. Shaktah R,Vardanyan L,David E,Aleman A,Orr D,Shaktah LA,Tamae D,Minehan T. (2020) Synthesis and Stereochemical Assignment of Conioidine A: DNA- and HSA-Binding Studies of the Four Diastereomers., 83 (10): [PMID:33034450] [10.1021/acs.jnatprod.0c00871] |
| 133. Sniecikowska J,Gluch-Lutwin M,Bucki A,Więckowska A,Siwek A,Jastrzebska-Wiesek M,Partyka A,Wilczyńska D,Pytka K,Pociecha K,Cios A,Wyska E,Wesołowska A,Pawłowski M,Varney MA,Newman-Tancredi A,Kolaczkowski M. (2019) Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT Receptor-Biased Agonists with Robust Antidepressant-like Activity., 62 (5.0): [PMID:30721053] [10.1021/acs.jmedchem.9b00062] |
| 134. Byun JS,Sohn JM,Leem DG,Park B,Nam JH,Shin DH,Shin JS,Kim HJ,Lee KT,Lee JY. (2016) In vitro synergistic anticancer activity of the combination of T-type calcium channel blocker and chemotherapeutic agent in A549 cells., 26 (3.0): [PMID:26739776] [10.1016/j.bmcl.2015.12.010] |
| 135. Mak JYW,Wu KC,Gupta PK,Barbero S,McLaughlin MG,Lucke AJ,Tng J,Lim J,Loh Z,Sweet MJ,Reid RC,Liu L,Fairlie DP. (2021) HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates., 64 (4.0): [PMID:33570940] [10.1021/acs.jmedchem.0c01967] |
| 136. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
| 137. Abdel-Halim M, Sigler S, Racheed NAS, Hefnawy A, Fathalla RK, Hammam MA, Maher A, Maxuitenko Y, Keeton AB, Hartmann RW, Engel M, Piazza GA, Abadi AH.. (2021) From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity., 64 (8.0): [PMID:33793216] [10.1021/acs.jmedchem.0c01120] |
| 138. Yokoyama T, Kashihara M, Mizuguchi M.. (2021) Repositioning of the Anthelmintic Drugs Bithionol and Triclabendazole as Transthyretin Amyloidogenesis Inhibitors., 64 (19.0): [PMID:34547896] [10.1021/acs.jmedchem.1c00823] |
| 139. Rullo M, Cipolloni M, Catto M, Colliva C, Miniero DV, Latronico T, de Candia M, Benicchi T, Linusson A, Giacchè N, Altomare CD, Pisani L.. (2022) Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies., 65 (5.0): [PMID:35195417] [10.1021/acs.jmedchem.1c01784] |
| 140. (2020) Pharmaceutical compounds and therapeutic methods, |
| 141. Fallot LB, Suresh RR, Fisher CL, Salmaso V, O'Connor RD, Kaufman N, Gao ZG, Auchampach JA, Jacobson KA.. (2022) Structure-Activity Studies of 1H-Imidazo[4,5-c]quinolin-4-amine Derivatives as A3 Adenosine Receptor Positive Allosteric Modulators., 65 (22.0): [PMID:36367749] [10.1021/acs.jmedchem.2c01170] |
| 142. Sun L, Zhang S, Kou S, Yi H, Cui A, Li Z.. (2022) Design, synthesis, and antibacterial activity of derivatives of Tryptophanyl-tRNA synthetase inhibitor indolmycin., 241 [PMID:35963132] [10.1016/j.ejmech.2022.114647] |
| 143. Li X, Guo T, Feng Q, Bai T, Wu L, Liu Y, Zheng X, Jia J, Pei J, Wu S, Song Y, Zhang Y.. (2022) Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs., 228 [PMID:34902735] [10.1016/j.ejmech.2021.114035] |
| 144. Hassan MZ, Osman H, Ali MA, Ahsan MJ.. (2016) Therapeutic potential of coumarins as antiviral agents., 123 [PMID:27484512] [10.1016/j.ejmech.2016.07.056] |
| 145. Moxam J, Naylon S, Richaud AD, Zhao G, Padilla A, Roche SP.. (2023) Passive Membrane Permeability of Sizable Acyclic β-Hairpin Peptides., 14 (3): [PMID:36923919] [10.1021/acsmedchemlett.2c00486] |
| 146. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
| 147. Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL.. (2019) Mapping human microbiome drug metabolism by gut bacteria and their genes., 570 (7762): [PMID:31158845] [10.1038/s41586-019-1291-3] |
